جستجوی استاد راهنمای دانشگاهی

Mogib Khedrمشاهده پروفایل

دانشگاهی

• Stem Cell Biology
• Tissue Engineering
• Cell Biology
• +۳ مورد دیگر

Dr. Mogib Khedr is a Senior Teaching Fellow at the University of Southampton, specializing in regenerative medicine and liver stem cell research. His work focuses on developing bio-artificial liver tissues using 3D culture systems, including acoustic fluid-based bioreactors and clay gel matrices. Collaborations with Prof. Martyn Hill and Dr. Jonathan Dawson highlight his interdisciplinary approach. He actively contributes to the British Association for the Study of the Liver and holds a Fellowship with Advance HE (2020). Research Areas: Liver stem cell regeneration, bioengineering, hepatocyte proliferation, and inflammation mechanisms Key Collaborators: Prof. Martyn Hill, Dr. Jonathan Dawson His research combines molecular biology with advanced materials science to address challenges in liver tissue engineering. Recent publications (2019-2011) explore growth factor effects on hepatocytes and mast cell mediator roles in inflammation. He also advises on clinical applications of bioengineered tissues. External Roles: Member of The British Association for the Study of the Liver (2018), Fellow of Advance HE (2020) Grants and funding details are not explicitly listed, but his active research portfolio indicates sustained academic engagement. He maintains labs focused on liver cell culture and biomaterial testing.

Xi Renمشاهده پروفایل

استادیار

• Tissue Engineering
• Regenerative Medicine
• Biomanufacturing
• +۷ مورد دیگر

Xi (Charlie) Ren is an Assistant Professor in the Department of Biomedical Engineering at Carnegie Mellon University's College of Engineering. He leads the Ren Lab, focusing on tissue engineering, vascular regeneration, and biomanufacturing. He is affiliated with the Bioengineered Organs Initiative and the Manufacturing Futures Institute. Education: Ph.D. in Cell Biology, Peking University (2011) BS in Biological Science, Peking University (2005) His research centers on engineering functional tissues using decellularized scaffolds, DNA nanotechnology, and organoid systems. Key areas include vascular engineering, lung regeneration, bioorthogonal functionalization, and synthetic cell protection. His lab develops innovative platforms such as apical-out airway organoids and DNA-based cell armor. The recent publications (2025–2023) highlight a strong trend in leveraging DNA nanotechnology for intracellular delivery and cell ruggedization, chemoselective biomaterial modification, and advanced organoid and vascular engineering. Keywords across these works include tissue engineering, regenerative medicine, nanotechnology, and extracellular matrix dynamics. Scientific Awards: NSF CAREER Award NIH Bioengineering Partnerships with Industry (BPI) Grant American Heart Association Collaborative Sciences Award BMES-CMBE Rising Star Award Charles E. Kaufman Foundation Grant Dean’s Early Career Fellow at CMU Ren actively mentors graduate students, including NIH-funded Ph.D. student Dhruv Bhattaram. He has secured major grants from NIH, NSF, ARPA-H, and the Kaufman Foundation, often in collaboration with institutions like the University of Pittsburgh and NASA. His work has significant translational potential in regenerative medicine and organ transplantation. He leads research in the Ren Lab, contributing to the Bioengineered Organs Initiative and advancing 3D micro-ice printing and DNA nanotechnology applications in medicine.

• Molecular Biology
• Genetics
• Oncology
• +۷ مورد دیگر

Salvatore Feo is a Full Professor at the Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (BIOS-14/A), University of Palermo. His research spans molecular biology, oncology, and bioinformatics with a focus on breast and colon cancer mechanisms, neuroplasticity, and proteomic/transcriptomic profiling. Key Research Areas Molecular interactions in cancer progression Epithelial-to-mesenchymal transition (EMT) Neuroplasticity and stress models Proteomic and transcriptomic analyses Nanoparticle-based cancer therapies Recent publications highlight his work on ENO1/Hsp70 interactions as therapeutic targets, THC-induced neuroplasticity alterations , and multi-omics approaches in cancer biology . While no awards or grants are listed, his contributions to understanding tumor biomarkers (e.g., S100 proteins, MMPs) and stress responses in myogenic progenitors are consistent themes. Collaborations with institutions on DNA-based biosensors and ionic liquid functionalization indicate interdisciplinary applications.

• Biomaterials
• Neural Regeneration
• Biomedical Engineering
• +۵ مورد دیگر

Zaida Álvarez Pinto is a Principal Investigator at the Institute of Bioengineering of Catalonia (IBEC) and an Assistant Professor in the Department of Medicine at the Feinberg School of Medicine , Northwestern University . She also holds a Visiting Scientist role at the Simpson Querrey Institute for Bionanotechnology . Her research focuses on neural regeneration , biomaterials , and spinal cord repair , utilizing supramolecular polymers , peptide amphiphiles , and synthetic extracellular matrix engineering . She explores applications in stem cell differentiation , neurodegenerative disease modeling , and nanotechnology-based therapies . Her recent publications emphasize dynamic bioactive scaffolds for neuronal survival, glycopeptide-amphiphile copolymers , and age-specific decellularized matrices in regenerative medicine. Trends include supramolecular motion for chondrogenic bioactivity, neural stem cell maturation , and antiviral nanofiber therapies . Scientific Awards : Young Baxter Investigator Award (2019) Rafael Hervada Award (2021) Women in Science Nanotechnology Award (2022) She holds 4 patents with AmphixBio Incorporation and consults for two biotechnology startups in the USA. Her work bridges biomaterials science and clinical translation for CNS repair.

Vanessa Montoya Uribeمشاهده پروفایل

پژوهشگر ارشد

• Pregnancy-induced heart disease
• Molecular biosciences
• Bioengineering
• +۷ مورد دیگر

Dr. Vanessa Montoya Uribe is a Post-Doctorial Research Associate at Texas A&M University, affiliated with the College of Agriculture & Life Sciences. She earned her B.S. in Biology from Universidad de Antioquia (2014), M.Sc. in Biology from University of Texas of the Permian Basin (2018), and Ph.D. in Molecular Biosciences and Bioengineering from University of Hawai’i at Mānoa (2023). B.S., Universidad de Antioquia, Biology, 2014 M.Sc., University of Texas of the Permian Basin, Biology, 2018 Ph.D., University of Hawai’i at Mānoa, Molecular Biosciences and Bioengineering, 2023 Her research spans molecular mechanisms in pregnancy-induced heart disease, fetal programming via endocannabinoids in maternal nutrient reduction models, and conservation biology of near-threatened plant species. Current work focuses on single-cell multi-omic analyses of human milk oligosaccharides in gnotobiotic mouse gut health and the genetic implications of mismatch repair loss in intestinal stem cells. Dr. Montoya Uribe has received multiple awards, including the John H. Doran Graduate Research Fellowship, Best Basic Science Oral Presentation Award at the 2017 TTUHSC Research Forum, and travel grants for international conferences. She has contributed to four publications across cardiovascular, nutrition, and microbiome research fields. As a member of Texas A&M AgriLife and its affiliated institutions, she integrates interdisciplinary approaches in biomedical sciences and agricultural life sciences.

Matthew D. Layneمشاهده پروفایل

دانشیار

• adipose tissue fibrosis
• mechanotransduction pathways
• extracellular matrix (ECM) synthesis
• +۷ مورد دیگر

Matthew D. Layne is an Associate Professor and Assistant Dean of Research Education at Boston University School of Medicine. His laboratory focuses on understanding the mechanisms of adipose tissue fibrosis and mechanotransduction pathways, with particular emphasis on the role of Aortic Carboxypeptidase-Like Protein (ACLP) in fibrotic processes. Dr. Layne received his PhD from Boston University School of Medicine and completed postdoctoral training at Brigham and Women's Hospital/Harvard Medical School. His educational background has prepared him for his current research focus on extracellular matrix (ECM) synthesis and assembly in relation to fibroproliferative and connective tissue diseases. Dr. Layne's research primarily investigates pathways controlling ECM synthesis and assembly as they relate to fibroproliferative and connective tissue diseases. His laboratory aims to identify therapeutic strategies for conditions involving fibroblast-myofibroblast differentiation and ECM remodeling, which are now recognized to play roles in organ fibrosis, cardiovascular diseases, metabolic/obesity disorders, and cancer. Central to his studies is determining the function of ACLP, a secreted, collagen-binding protein that enhances fibrosis and myofibroblast differentiation through mechanisms involving TGFβ receptor signaling and mechanical signaling pathways. Recent work has uncovered the role of ACLP and AEBP1 genetic mutations in Ehlers Danlos Syndrome and aortic aneurysm. Dr. Layne's publication record demonstrates consistent focus on adipose tissue biology, fibrosis mechanisms, and connective tissue disorders. His recent work has expanded into understanding how obesity-related conditions affect lymphatic function and how ACLP regulates vascular progenitor cell fate. The research shows progression from basic molecular mechanisms to translational applications, with increasing focus on therapeutic implications of his findings. Dr. Layne actively mentors graduate students, MS/MAMS students, and undergraduates in his laboratory. Current laboratory members include PhD students Scott Connelly, Cheyanne Frosti, Alexander Tavares, and Diana Yeritsyan, along with undergraduate students Alexander Yurochko and Benjamin Werner, and MS student Loren Peretz. His lab offers research opportunities for graduate students through the Program in Biomedical Sciences (PiBS) at BUSM, as well as for BU MS/MAMS students and undergraduates. Dr. Layne's laboratory maintains active research projects including: uncovering new mechanisms that control adipose tissue remodeling and fibrosis, defining the role of ACLP in mechanotransduction pathways that control progenitor cell fate, and investigating the mechanisms of how ACLP/AEBP1 mutations cause Ehlers Danlos Syndrome (EDS).

• Biomedical Engineering
• Dentistry
• Biochemistry and Cell Biology
• +۳ مورد دیگر

Farahnaz Fahimipour serves as an Assistant Professor in the Department of Periodontology at the University of Alabama at Birmingham School of Dentistry since 2022. She holds a PhD in Dental Materials from Tehran University of Medical Sciences (2020) and clinical certifications in Periodontology (UNC Chapel Hill, 2022). PhD in Dental Materials, Tehran University of Medical Sciences (2020) MS in Dental Clinical Sciences, UNC Chapel Hill (2022) Clinical Certificate in Periodontology, UNC Chapel Hill (2022) Her research bridges biomedical engineering and dentistry , focusing on innovative biomaterials for tissue regeneration. Key areas include: microneedle drug delivery systems for periodontal inflammation, mechanically adaptive hydrogels mimicking biological tissues, and 3D-printed nanocomposite scaffolds enhancing stem cell osteogenesis. Notably, she explores epigenetic mechanisms in periodontal disease progression and its systemic implications. Recent publications demonstrate expertise in polymer science for injectable implants, microfluidic fabrication of growth factor delivery systems, and multi-scale materials characterization . Her work on periodontitis-renal disease interactions reveals persistent organ-level pathophysiological changes post-treatment. Teaching activities include mentoring graduate student theses (Ethan Madison, Lincoln Nguyen) and delivering specialized courses in Periodontal Case Conferences and Surgical Implants (2023-2024).

Joshua Moreauمشاهده پروفایل

استادیار

• tissue specific immunity
• adaptive immunity
• cutaneous immunology
• +۴ مورد دیگر

Joshua Moreau is an Assistant Professor at Oregon Health & Science University (OHSU) with appointments in the Division of Oncological Sciences, Department of Dermatology, and Department of Cell, Developmental & Cancer Biology. He is also affiliated with CEDAR (Center for Spatial Systems Biomedicine). PhD in Immunology from the University of Toronto Postdoctoral Fellowship at the University of California, San Francisco (UCSF) under Dr. Michael Rosenblum His research focuses on the intersection of adaptive immune function and tissue biology, particularly the role of tissue-resident lymphocytes in barrier organs like the skin. Key areas include inflammatory disease, cancer immunology, and tissue-specific immunotherapy. He employs multiomic approaches and functional immunology to study disease pathogenesis and develop novel therapeutic strategies. His recent publications highlight work on hidradenitis suppurativa, melanoma, regulatory T cells, layilin-glycosylated collagen interactions, and 3D tumor-immune modeling. His research spans molecular immunology, tissue engineering, and translational applications. Melanoma Research Alliance Young Investigator (2024-2027) Human Frontier Science Program Fellow (2018-2021) Cancer Research Society SNGS Award (2021) Moreau has collaborated on studies involving immune privilege in the hair follicle, TGF-β activation during skin barrier breach, and the role of tertiary lymphoid structures in sustaining B cell activity. His work bridges fundamental immunology with clinical applications in dermatology and oncology.

Jonathan Arye Gerstenhaberمشاهده پروفایل

استادیار

• Bioengineering
• Biomaterials
• Tissue Engineering
• +۵ مورد دیگر

Jonathan Arye Gerstenhaber is an Assistant Professor of Instruction in the Department of Bioengineering at Temple University's College of Engineering. He is actively involved in undergraduate bioengineering education, teaching foundational and design-oriented courses such as Modeling Fundamentals, Programming Fundamentals, Biomedical Instrumentation, and the Biodesign elective. His academic role emphasizes pedagogical innovation and hands-on laboratory learning. His research and scholarly work focus on bioengineering education, biomaterials, and regenerative medicine. He has contributed to the development of virtual laboratory environments, particularly during the pandemic, and has collaborated on tissue engineering projects involving human induced pluripotent stem cells (hiPSCs) for cardiac and retinal applications. His work bridges educational practice with cutting-edge bioengineering research. The recent publications highlight a strong trend in applying bioengineering principles to regenerative medicine, particularly in stem cell differentiation and scaffold design. Additionally, a significant contribution lies in the field of bioengineering education, with innovations in virtual lab instruction. These efforts reflect a dual commitment to advancing both teaching methodologies and translational research. Scientific Awards: No awards listed in the provided text. Dr. Gerstenhaber is actively engaged in curriculum development and collaborative research. He has been involved in grant-supported or collaborative projects related to tissue engineering and educational technology, though specific grants are not detailed. His advising activities are not explicitly listed, but his role as an instructor and lab course leader suggests mentorship of undergraduate researchers and design teams. He contributes to the Bioengineering department’s educational mission through lab course development and innovative teaching strategies. His work supports the integration of experiential learning into the undergraduate bioengineering curriculum at Temple University.

Evangelia Bellasمشاهده پروفایل

دانشیار

• Bioengineering
• Tissue Engineering
• Adipose Tissue Biology
• +۱۲ مورد دیگر

Evangelia Bellas is an Associate Professor in the Department of Bioengineering at Temple University's College of Engineering. Her research focuses on engineering functional adipose tissue models to study metabolic diseases, vascularization, and cellular responses to mechanical and environmental cues. She is actively funded by NIH, NASA, NSF, Lipedema Foundation, and VentureWell. Research Interests: Adipose Tissue Biology and Disease Modeling Angiogenesis and Vascular-Adipose Interactions Cell Mechanics and Mechanotransduction Biomaterials and 3D Tissue Engineering Obesity, Type 2 Diabetes, and Lipedema Soft Tissue Regeneration The recent publications indicate a strong trend toward developing microphysiological systems ('fat-on-chip') to model adipose tissue under various conditions, including hypoxia, microgravity, and matrix stiffness. These studies emphasize the role of mechanical and microenvironmental factors in adipocyte function, fibrosis, and metabolic regulation, often using advanced 3D in vitro platforms and stem cell models. Scientific Awards: NSF CAREER Award (2021) BMES - Cell and Molecular Bioengineering Young Innovators Award (2021) BMES - Rising Star Award (2023) ASMB - Junior Investigator Award (2023) Dr. Bellas is actively involved in mentoring and academic leadership. She teaches undergraduate and graduate courses such as The Bionic Human and Principles of Tissue Engineering . Her research has been supported by competitive grants from federal and private organizations. She also leads the BellasFATLab, which specializes in adipose tissue engineering and mechanobiology. Additionally, she plays a significant role in diversity, equity, and inclusion efforts, having served as Chair of the Biomedical Engineering Society’s Diversity Committee and currently as Vice-Chair of the BME Council of Diversity Chairs. Laboratory: BellasFATLab

Gina Kusumaمشاهده پروفایل

پژوهشگر ارشد

• Stem Cell Biology
• Biomaterials
• Extracellular Vesicles
• +۳ مورد دیگر

Gina Kusuma is a Research Fellow at the Department of Obstetrics & Gynaecology , Monash University , and a Research Scientist at the Hudson Institute of Medical Research . She joined the Amnion Cell Biology Laboratory under A/Prof Rebecca Lim in 2017, focusing on clinical-scale production of extracellular vesicles and bioengineering paracrine signaling for therapeutic applications. PhD in Stem Cell Biology, University of Melbourne (2015) Her research integrates Biomaterials and Stem Cell Biology to explore how Extracellular Vesicles and MicroRNA Signaling can enhance Regenerative Medicine approaches. She has pioneered work on substrate stiffness tuning for liver disease and cell-free therapies for vascular regeneration. Recent publications highlight trends in Extracellular Vesicle Potency across 2D/3D culture systems, Mesenchymal Stem Cell Applications in perinatal lung disease, and Bioprocessing Optimization for clinical scalability. A key innovation involves leveraging Mechanotransduction principles to maximize therapeutic outcomes. Scientific Awards : Arthur Nyulasy Prize (2020) CASS Foundation Travel Award (2017) Hudson Institute Postdoctoral Travel Award (2018) ISEV Young Investigator Scholarship (2018) Victoria Fellowship (2019) As Associate Editor for Frontiers in Pharmacology (2019–present), she contributes to editorial peer-review. Her work aligns with UN Sustainable Development Goals in health and innovation.

Simon Fosterمشاهده پروفایل

پژوهشگر ارشد

• Molecular Pharmacology
• Cardiovascular Physiology
• G Protein-Coupled Receptor Biology
• +۴ مورد دیگر

Simon Foster is an Adjunct Research Fellow in the Department of Pharmacology at Monash University's Biomedicine Discovery Institute. He currently serves as a Senior Research Officer at QIMR Berghofer Medical Research Institute's Cardiac Bioengineering Group, where he focuses on signaling pathways underlying cardiac fibrosis using stem-cell derived human cardiac organoids. His work continues in collaboration with Prof Martin Stone on chemokine signaling, supported by an NHMRC Ideas Grant. Dr. Foster's research interests center on molecular pharmacology and cardiovascular physiology with a particular focus on cell signaling and G protein-coupled receptor (GPCR) biology. His work investigates chemokine-receptor interactions, which control leukocyte recruitment during inflammation and are critical targets for developing novel therapeutic agents against inflammatory diseases. His research has significant implications for understanding and controlling cardiac fibrosis and inflammatory disease mechanisms. Dr. Foster has received competitive Postdoctoral Research Fellowships in 2015 and serves as a peer reviewer for prestigious journals including Journal of Biological Chemistry, Frontiers in Physiology, and Science Signaling. He has been active in professional organizations, serving as the Victorian representative for the Drug Discovery Special Interest Group Committee of ASCEPT in 2019. Postdoctoral Research Fellowship (2015) Postdoctoral Research Fellowship (2015) His research activities include extensive publication output with 33 research outputs documented, including high-impact publications in Cell, Molecular Pharmacology, and Pharmacology & Therapeutics. His work has generated significant academic attention with multiple publications receiving over 100 citations. Dr. Foster has led research projects including 'Decoding fibrotic signalling mechanisms to identify new heart failure therapeutic targets' (2021-2022) and 'Decoding monocyte signalling networks' (2020-2021). Dr. Foster is actively involved in the Cardiac Bioengineering Group at QIMR Berghofer, where his team utilizes advanced techniques including stem-cell derived human cardiac organoids to investigate the molecular mechanisms underlying cardiac fibrosis and inflammatory responses.

David Gurevichمشاهده پروفایل

پژوهشگر ارشد

• Developmental Biology
• Regenerative Medicine
• Stem Cell Biology
• +۷ مورد دیگر

David Gurevich is a Dr Sir Henry Dale University Research Fellow and Proleptic Lecturer in the Department of Life Sciences at the University of Bath, Faculty of Science. He is affiliated with the Centre for Therapeutic Innovation and the Centre for Bioengineering & Biomedical Technologies (CBio), reflecting his interdisciplinary research in developmental and regenerative biology. He is actively involved in research, supervising doctoral students, and collaborating with institutions such as Monash University and the Victor Chang Cardiac Research Institute. Research Interests: His work focuses on understanding the cellular and molecular mechanisms underlying tissue regeneration and development, primarily using zebrafish models. Key areas include stem cell biology, organogenesis, signaling pathways (Wnt, Notch, Hippo), and immune-regeneration interactions. His research integrates live imaging, single-cell genomics, and genetic screening to uncover fundamental principles of regenerative processes. The trends in his recent publications show a consistent focus on regenerative mechanisms across multiple organs—heart, retina, fin, kidney—highlighting a systems-level approach to understanding repair and development. His work bridges developmental biology, bioengineering, and translational medicine, contributing to the broader field of regenerative therapies. Scientific Awards: Sir Henry Dale Fellowship Advising and Grants: Dr Gurevich is accepting doctoral students and leads independent research supported by the Sir Henry Dale Fellowship, a prestigious award jointly funded by the Royal Society and Wellcome Trust. His collaborative network spans multiple departments at the University of Bath and international institutions, indicating active grant involvement and mentoring responsibilities. Labs and Teams: He is embedded in interdisciplinary research centers including CBio and the Centre for Therapeutic Innovation, working alongside experts in bioengineering, mathematical modeling, and clinical translation. His lab likely operates within a collaborative, team-science framework focused on advancing regenerative medicine through innovative experimental approaches.

Mohsen Akbariمشاهده پروفایل

دانشیار

• Biomedical Engineering (Bio-MEMS)
• Tissue Engineering
• Organs-on-Chip
• +۵ مورد دیگر

Mohsen Akbari is an Associate Professor in the Department of Mechanical Engineering at the University of Victoria (UVic). His research focuses on the intersection of cellular biology, biomaterials, and microengineering, with key areas including biofabrication of engineered tissues, biomimetic tissue modeling, and advanced drug delivery systems. Akbari leads the Laboratory for Innovations in MicroEngineering (LiME), which emphasizes interdisciplinary collaboration and hands-on training for students in microscale platform design, tissue engineering, and polymer synthesis. His academic credentials include a BSc, MSc (both from Sharif University of Technology), and a PhD from Simon Fraser University, followed by a postdoctoral fellowship at Harvard Medical School and the Wyss Institute. Akbari’s work has led to innovations such as smart wound dressings (e.g., GelDerm), multifunctional hydrogels, and microfluidic-based sensors for disease monitoring. His lab actively collaborates with industry partners like RepliCel and Eupraxia Pharmaceuticals, and has secured funding from organizations like NSERC and CIHR. Notable achievements include the 2019 Idea to Commercialization Award and the development of the smart bandage technology highlighted in Advanced Healthcare Materials. Akbari’s publications span biomaterials, microfluidics, and regenerative medicine, with a focus on translational applications in healthcare. He is also an advocate for student training, mentoring over 20 graduate and undergraduate researchers since 2017, many of whom have won prestigious awards and scholarships. Current research priorities include 3D-printed drug delivery systems for glioblastoma, bioengineered tumor models for drug screening, and the integration of sensors into wearable medical devices. The LiME lab maintains active partnerships with institutions like the Technical University of Denmark and University of Manitoba, reflecting its global impact in biomedical engineering.

Yaakov Nahmiasمشاهده پروفایل

استاد

• Metabolic Engineering
• Liver Tissue Engineering
• Hepatitis C Virus Research
• +۴ مورد دیگر

Prof. Yaakov Nahmias is a Professor and Managing Director at the Hebrew University of Jerusalem's Silberman Institute of Life Sciences, Department of Genetics. His research focuses on bioengineering applications in metabolism, tissue engineering, and drug discovery. His lab develops organ-on-chip systems, sensors for toxicity studies, and cultivated meat technologies. Key projects include metabolic control of viral infections, kidney nephrotoxicity mechanisms, and cost-effective bioprocessing for cultured meat. Research Interests: Metabolic programming and nuclear receptor control Liver tissue engineering and HCV infection Organ-on-chip platforms for drug discovery Cultivated meat production and bioprocessing innovations Scientific Awards: AIMBE Fellow, ERC Consolidators Grant (2015), Rosetrees Trust Prize (2017), and Rappaport Prize (2014). Lab Members: Includes researchers like Mohammad Ghosheh and Aaron Cohen. Collaborations span Grass Center for Bioengineering and Tissue Dynamics.